Success Stories: EB1A Approval for a Research Associate in the field of Biophysics in just 2 days
Client’s Testimonial:
Thanks For all your kind help and strong support, without your help it would not have been possible. I will surely recommend you to my friends around, and I am sure you will get some client by referrals. Once again, thanks!
On September 5th, 2013 we received another EB1-A (Alien of Extraordinary Ability) Approval for a Research Associate in the field of Biophysics (Approval Notice)
General Field: Biophysics Position at the Time of Case Filing: Research Associate National Origin: India Service Center: Nebraska Service Center (NSC) State of Residence at the Time of Filing: Colorado Approval Notice Date: September 5, 2013 Processing Time: 2 days (Premium Processing Service requested)
Case Summary:
The client in this case was a Research Associate from India in the field of biophysics. He had conducted his research in the highly specialized areas of biophysics, molecular biology, pharmaceutical sciences, and biochemistry. His work had resulted in at least 11 peer-reviewed scientific articles published in leading journals, one book chapter, and numerous presentations at national and international conferences and seminars. At the time that his case was filed, his publications had accumulated at least 385 citations, clearly demonstrating that he had influenced his field and garnered international acclaim. In addition, he had reviewed at least 15 articles for different journals. Of his accomplishments, one of his independent recommenders remarked, “[Client] is an experienced, premier researcher in biomedicine and pharmaceutical biotechnology. His work has implications on an international level and relates directly to our understanding of major diseases and other matters of public health.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of biophysics, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in just 2 days.

